Cargando…
Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin
Carrier peptides, termed protein transduction domains (PTDs), serve as provide promising vehicles for intranasal delivery of macromolecular drugs. A mutant PTD derived from human translationally controlled tumor protein (TCTP-PTD 13, MIIFRALISHKK) was reported to provide enhanced intranasal delivery...
Autores principales: | Bae, Hae-Duck, Lee, Joohyun, Jun, Kyu-Yeon, Kwon, Youngjoo, Lee, Kyunglim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058520/ https://www.ncbi.nlm.nih.gov/pubmed/29688087 http://dx.doi.org/10.1080/10717544.2018.1464081 |
Ejemplares similares
-
Optimization of formulation for enhanced intranasal delivery of insulin with translationally controlled tumor protein-derived protein transduction domain
por: Bae, Hae-Duck, et al.
Publicado: (2019) -
Modified translationally controlled tumor protein-derived protein transduction domain enhances nasal delivery of exendin-4 as shown with insulin
por: Bae, Hae-Duck, et al.
Publicado: (2018) -
Protein transduction domain of translationally controlled tumor protein: characterization and application in drug delivery
por: Maeng, Jeehye, et al.
Publicado: (2022) -
Insulin Induces Phosphorylation of Serine Residues of Translationally Controlled Tumor Protein in 293T Cells
por: Maeng, Jeehye, et al.
Publicado: (2015) -
PEGylation improves the therapeutic potential of dimerized translationally controlled tumor protein blocking peptide in ovalbumin-induced mouse model of airway inflammation
por: Seo, Hyeran, et al.
Publicado: (2022)